The first steps have begun to find Petplan and The Veterinary Business Journal's Practice Manager of the Year for 2012.
Nominations are now being sought for the most accomplished UK practice managers and recommendations are welcome from any member of the veterinary team.
Three finalists will be chosen and the winner announced at the annual Petplan Veterinary Awards in April 2012.
Robin Fearon, editor of the Veterinary Business Journal, said: "It is a distinct pleasure to launch the awards programme each year knowing that at the end of it we will be able to announce another winning practice manager.
"These awards are so important in promoting the role and highlighting the crucial part that managers play in practice strategy and success - we can't wait to see your nominations."
Judges will assess candidates' applications and choose the three finalists based on their competency in areas such as staff development, financial strategy and marketing initiative.
Last year's winner Denise Coston is practice manager at Castle Veterinary Surgeons in County Durham. She said: "Winning this award has meant a lot to me because it makes you feel valued. I would say to anyone thinking of nominating their practice manager: 'just do it'.
"The role of practice manager varies in each practice and can be hard to quantify with specific measures, but it means a lot to celebrate someone getting it right. It is an excellent way to promote the role of practice manager and it is great to get recognition alongside vets and nurses."
This award is supported by the Society of Practising Veterinary Surgeons and the Veterinary Practice Management Association.
As well as a plaque commemorating their achievements, the winner will once more receive one year's free membership to the VPMA.
Nominations for this year's award close on 10 February 2012. Application packs are available from: Jackie Morrison, The Veterinary Business Journal, Olympus House, Werrington Centre, Peterborough PE4 6NA, or e-mail jackiemorrison@vbd.uk.com.
Alternatively visit www.vetsonline.com/ to download yours direct.
The Royal College of Veterinary Surgeons has refused to release the McKelvey Report in full, despite Freedom of Information requests made by VetSurgeon.org and others.
According to the College, it had always been the intention of RCVS Officers that the full report, which considered the building works in the Lower Ground Floor of the RCVS offices in Belgravia House, and the implementation of a new database, would be published.
However, on the advice of solicitors (Penningtons), only the recommendations of the Report were published initially, in November.
This publication followed discussion of the full report (one sentence was redacted on legal advice) by RCVS Council on 3 November.
Freedom of Information requests for the full report were then received by the College, so further, external senior legal advice was sought.
This advice, from Counsel, confirmed the original view from solicitors that it would be inappropriate to publish the report in full because it includes personal data, which ought not to be made public, under the Data Protection Act.
The College claims the meat of the report is in the recommendations, which account for approximately 50% of the report, and which are being taken forward by Officers and RCVS Council, with plans to put an Audit and Risk Committee in place taking priority.
The recommendations of the report, which were adopted by Council, were published online on 11 November and are available to download from the 'Related documents' box, above right.
Vygon Vet has launched two new 'procedure packs' containing disposable essentials for unblocking a tomcat or performing a spay or minor surgery.
The KatKath Urinary Catheter Insertion Pack contains a catheter, a drape towel, polypropylene suture, lubricating gel, a Luer-slip syringe and a clear tray. The complete set costs £10.99.
Vygon Vet General Manager Chris Kenyon, said: "Not only does our KatKath pack ensure everything that's needed is in one place and sterile, it can also save vets up to 50% compared with prices if they buy similar products separately. It's a win-win situation."
The Spay Tray and Minor Operations Set (pictured right) includes a selection of forceps, a Mayo Hagar needle holder, a scalpel, a pair of dissecting scissors, a hand towel, drapes, a tray and five radiopaque swabs.
Chris said: "Our Spay Tray and Minor Ops Sets are produced to the highest standards using top quality materials. Having the required items in one pack eradicates the need to go through the expensive process of washing, re-packing and re-sterilisation, and from an admin point of view invoicing is easy with one single code covering all the different pack parts."
The Spay Tray and Minor Ops Sets are available for an introductory price of £12.50 for a limited period.
In the blurb, Vygon Vet says the benefits of its procedure packs include:
The company is also offering a retrieval service through which the instruments from up to ten packs can be disposed for £14.50.
For more information, visit www.vygonvet.co.uk, telephone: 01793 748900 or visit Vygon Vet at the forthcoming BSAVA Scottish Congress (29-31st August at the Edinburgh Conference Centre).
The trial starts on Monday 11 July and will continue for three months to allow the College to determine levels of demand for such a service and, therefore, whether it should be made permanent.
Eleanor Ferguson, RCVS Acting Registrar, said: "This was a potential service identified in our Strategic Plan as a way of allowing veterinary professionals to have informal, confidential, discussions with members of the Professional Conduct Department about potential fitness to practise issues, short of formally raising a concern.
"Although any discussions via the new reporting line or email address will be confidential, if a veterinary surgeon or a veterinary nurse subsequently wishes to raise a formal concern about another veterinary professional, then they generally will need to identify both themselves and the individual in order to take it through our investigation process.
"We have developed a bespoke concerns form for members of the professions who do want to raise concerns about other professionals."
Veterinary surgeons and veterinary nurses who wish to contact a member of the RCVS Professional Conduct Department in confidence can do so by calling 07599 958 294 between 9am and 5pm, or by emailing reporting@rcvs.org.uk.
The bespoke concerns from for members of the profession can be downloaded from www.rcvs.org.uk/concerns.
There are 15 candidates contesting six places in the RCVS Council; 16 if you include the perennial Dr Lonsdale. Three are existing Council members eligible for re-election and the remaining 13 candidates are not currently on Council:
Ballot papers and candidates’ details are due to be posted to all veterinary surgeons eligible to vote during the week commencing 13 March, and all votes must be cast, either online or by post, by 5pm on Friday 28 April 2017.
Once again the College is inviting members of the profession to ‘Quiz the candidates’ by putting their questions directly to all those standing for election. Each candidate will then be invited to choose two questions to answer from all those received, and produce a video recording of their answers. Recordings will be published on the RCVS website on Thursday 16 March.
The biographies and statements for each candidate in the elections can be found at www.rcvs.org.uk/vetvote17.
Eleanor Ferguson, RCVS Registrar, said: "This year we will be publishing the candidate biographies and statements online ahead of the start of the official voting period. This is to allow both veterinary surgeons and veterinary nurses to be better informed about the candidates and their reasons for standing before they put their questions forward.
"We would strongly encourage all members of the professions to review the candidate profiles and pose questions for them to answer. We hope it will spark some interesting debates about how the profession is regulated."
You can email your question (NB only one per person) to vetvote17@rcvs.org.uk, post it on the College’s Facebook page (www.facebook.com/thercvs) or on Twitter using the hashtags #vetvote17, by midday on Monday 27 February.
Merial Animal Health has revealed the latest MOO test figures which suggest that the productivity of four out of five UK dairy herds is compromised by high levels of gutworm.
The company says it has been helping dairy farmers to assess the level of gutworm challenge in their herds since 2009 by supporting and promoting MOO tests. The test measures the level of antibody to gutworm (Ostertagia ostertagii) that is present in a bulk milk sample and can determine if the herd has been exposed to low, medium or high challenge.
Data from five years of MOO tests shows that whilst there was a steady reduction in the number of herds with a high challenge between 2009 and 2013, the figure rose in 2014. In 2009, 93% of herds tested high and by 2013 this had fallen to 71% but this rose again to 88% last year.
Merial says that whilst these figures show an overall reduction in challenge since 2009, levels of gutworm across the UK dairy herd are still very high. Those animals affected will suffer from the negative impact of a parasite burden on productivity and fertility.
Between 2009 and 2014 nearly 900 dairy herds across the UK have been tested. During that time several counties had significant numbers of herds with high gutworm challenge results. This included Cheshire (85%), Cornwall (93%), Cumbria (91%), Dyfed (92%), Lancashire (90%), North Yorkshire (83%), Shropshire (86%), Somerset (86%), and Staffordshire (83%).
Sioned Timothy, veterinary adviser for Merial Animal Health, said: “Gutworm can significantly reduce the productivity of the herd. Although adult dairy cows develop immunity to gutworm that makes them resilient to outward clinical signs of infection, it does not prevent them from becoming infected with Ostertagia ostertagi. This parasite burden can reduce milk yield by as much as 2.6 litres per cow per day1”
She continued: “Gutworm may also have a negative impact on fertility. Removing damaging gutworms from dairy cows may improve their fertility and has been linked to reduced calving to conception intervals and improved conception rates2 to levels comparable with animals without a gutworm burden.
"Calving is another key period in the production cycle. Optimising cow and heifer management during this period is critical to the animal’s health and productivity throughout the subsequent lactation. Cows treated for gutworms around the time of calving have been shown to increase their grazing time by almost an hour compared to untreated cows3. Improved appetite and higher dry matter intake helps cows to bridge the energy gap; maximising their production, and reducing the time it takes to get them back into calf4.”
The MOO test figures show that the UK dairy herd continues to be affected by high levels of gutworm challenge. At a time when maximising productivity is vital to dairy business success, farmers should seriously consider testing their herd this autumn and develop a treatment plan with their vet or animal health adviser based on the result.”
MOO tests will be available in autumn 2015. The results of MOO tests are sent to both the farmer and their vet or animal health advisor, to enable them to determine the best course of action and treatment.References1 Reist et al, Effect of eprinomectin treatment on milk yield and quality in dairy cows in South Tyrol, Italy. Veterinary Record 2011 168, 484-487 Vet Rec 2002151:377-3802 McPherson et al. Proceedings of the American Association of Veterinary Parasitologists. 44th Annual Meeting, New Orleans, Louisiana, USA, 1999 Abstr. 28.3 Forbes et al. Behavioural mechanisms underlying production responses in dairy cows treated with eprinomectin. 19th WAAVP Congress 2003, New Orleans4 Sanchez et al. The effect of eprinomectin treatment at calving on reproduction parameters in adult dairy cows in Canada. Preventative Veterinary Medicine 2002 56:165-177
The National Office of Animal Health has issued a statement criticising the All Party Parliamentary Group on Antibiotics report: "Non-human uses of antibiotics: time to restrict their use?”, saying it fails to recognise the steps that have already been taken by vets and farmers to prevent disease and minimise antibiotic use on farms where possible.
NOAH chief executive Dawn Howard said: "NOAH fully supports the need for responsible prescribing, by both the veterinary and medical professions.
"On the veterinary side, NOAH has been very actively involved with responsible use initiatives, such as the RUMA Alliance, which publishes guidelines supporting responsible use and has produced an action plan on livestock antibiotic resistance to implement Government strategy.“
NOAH highlights two particular aspects of the report. Firstly that it is critical of the treatment of groups of animals through medicated feed and water.
Dawn said: "There are many animal-friendly reasons why medicines can be prescribed in this way by a veterinary surgeon.
"For groups of animals, fish or birds there is less stress than injection or individual oral dosing. Where treatment is needed, the vet supplies a prescription for treatment through medicated feed or through the water, depending on the product being used. The whole process is highly regulated through European and national legislation."
The report also suggests certain classes of antibiotics should be reserved for humans. NOAH says it believes that veterinary surgeons need to retain the full range of currently licensed antibiotics in order to be able to treat the range of conditions that affect animals, and if they are restricted, animal welfare will undoubtedly suffer.
NOAH adds that removal of some classes from the veterinary sector would place undue selective pressure on the remaining classes which could increase resistance to those classes – having the opposite effect to what the committee probably intends.
Dawn said: “NOAH is disappointed not to have been consulted in advance of the publication of the report. We believe that responsible use of veterinary antibiotics is the best way to help preserve these precious medicines for us all, without compromising the health and welfare of our animals.”
Underlying the plan are three 'Brexit Principles', devised by the College and formally adopted by RCVS Council, which will guide the College’s relationship with the Government during the forthcoming Brexit negotiations.
The College says each Principle is supported by a number of specific policies that the College will lobby for in the coming months, all designed to positively engage with the post-referendum reality and with government policy.
The Principles are:
RCVS Chief Executive Nick Stace said: "It is crucially important for the College and the profession as a whole to think boldly about the post-Brexit future; we cannot expect government to give us all of the answers, instead we must work to find solutions ourselves so as to shape the future of the profession from within."
The College has also asked the Institute for Employment Studies (IES) to undertake research into the attitudes and intentions of all EU-graduated veterinary surgeons and veterinary nurses currently working in the UK. They will all have receive a personalised email from IES with a link to this online survey, and their answers will help inform the College’s approach to Brexit. This research will help the College to understand better the impact that Brexit may already be having, how it can support EU veterinary professionals working in the UK, and build an evidence base regarding the potential impact that Brexit may have on the veterinary workforce.
For more information on the College’s Brexit activities, visit: www.rcvs.org.uk/brexit
Eilona's is one of 50 new jobs created by the company in the last 12 months alone, across a range of positions including veterinary surgeons, nurses and client care co-ordinators.
Eilona said: "White Cross Vets has an unrivalled reputation for offering exceptional pet care, as well as being recognised as a great place to work, which really appealed to me. To become the group’s 200th employee is fantastic and I’m really looking forward to the opportunities and challenges that lie ahead."
Tim Harrison, Managing Director of White Cross Vets, said: "Welcoming 50 new team members into the White Cross family in the last 12 months is a major coup and we’re delighted to have created a 200 strong team with Eilona’s appointment. We are already planning to expand our team further over the coming months, with three new practices due to open before the end of this year, which makes it a very exciting time for us."
Nominations will remain open till 5pm on Tuesday 31 January 2023 and the elections will take place in March and April 2023.
RCVS President Dr Melissa Donald, a member of RCVS Council since 2016, said: “I am a general practitioner by background, and so having the opportunity to serve on Council and be at the heart of decision-making that has a real and consequential impact on how we as vets work and conduct ourselves, has been a real privilege.
“In my six years on Council I’ve had the opportunity to be involved in fascinating debates and discussions, to represent the RCVS and its activities at country fairs and congresses, and to talk to and get the views of peers and colleagues from across the UK.
"Serving your profession in the RCVS is a fantastic opportunity and I would recommend anyone who wants to have a real say and impact on the future of the profession to stand for next year’s Council elections.”
The full eligibility criteria, info and FAQs for vets who want to stand can be found at: www.rcvs.org.uk/rcvscouncil23.
Prospective candidates for RCVS Council can also contact Melissa Donald for an informal conversation about what it means to be an RCVS Council member: president@rcvs.org.uk.
There is also an opportunity for prospective candidates to attend a meeting of the RCVS Council on Thursday 19th January 2023 at the University of Nottingham Veterinary School, as an observer.
Contact Dawn Wiggins, RCVS Council Secretary, on d.wiggins@rcvs.org.uk if you'd like to go.
Pfizer Animal Health has confirmed that the agreement to acquire multiple product franchises from the Schering-Plough Corporation has been completed - and approved by the European Commission. Pfizer has acquired these assets for approximately euro 116 million in cash.
The agreement covers all European Union countries and the franchises include all major animal health species including cattle, swine, equine and companion animal. Pfizer executives say the agreement leaves them with the most in-depth coverage of therapeutic areas, and the most highly recognised brands, in the industry. Precise details of the agreement are not being released although additional information on the products concerned will be the subject of further announcements in due course.
Pfizer has acquired certain rights to the following products in the European Economic Area:
Albert Bourla, President of Pfizer Animal Health in Europe, said: "This represents a significant expansion of our product portfolio and strengthens our long term commitment not just to veterinary surgeons, but also to farmers and pet owners. Pfizer spends hundreds of millions of dollars on research and development every year, and brings more new products to market than any other company, but when the opportunity arose to add well known, well respected brands to a portfolio that is already extremely strong, we had little hesitation in taking it."
Veterinary nurse Beverley Burnett has launched North East CPD, a new CPD provider in the North East of England.
Beverley said: "It's not always time- or cost-effective to have to travel far and wide for courses, sometimes overnight, leaving surgeries short-staffed, and what with increasing travel costs, I decided to provide courses further North.
"Courses for both veterinary surgeons and veterinary nurses start in October. Our lecturers are all very experienced professionals, qualified to the highest standard within their chosen speciality, giving you the opportunity to receive only interesting and up-to-date courses.
"Our aim is to help you develop your knowledge and skills, whilst enjoying a relaxed and friendly environment, at an affordable rate."
To find out more about current and future courses, and how to book, visit http://www.ne-cpd.co.uk/ or email: info@ne-cpd.co.uk
North East CPD is curently offering a 10% discount on your first booking!
Hysolv Animal Health UK has announced that it is offering a free diagnostic test which allows vets to identify the E. coli sub-types that produce the Shiga toxin associated with oedema disease in pigs.
The test, known as STEC-Check and worth £150-£200, is being sponsored by IDT Biologika GmbH. In the UK and Republic of Ireland, faeces and/or intestinal samples will be sent to the Animal Health and Plant Agency (APHA), Weybridge and SAC Consulting Veterinary Services at Penicuik to confirm results within a few days.
Hysolv says the test will provide a quick and accurate diagnosis, enabling appropriate action, including vaccination, to be taken on the farm.
Richard Brealey from Hysolv said: "Oedema disease is not always obvious and may be masked or controlled by the use of antibiotics, the use of zinc oxide or low-protein feeds which can also negatively affect productivity. This test will help confirm the presence of Shiga-toxin producing E. coli on the farm, a cause of serious losses in individual herds. We are therefore advising farmers to contact their vets to discuss using STEC-check on their farms."
According to the company, a nationwide study in Germany showed that 59% of farms where oedema was suspected were affected by Shiga toxin.
Richard added: "The Ecoporc Shiga vaccine has been recently licensed for use in the UK. There is pressure on vets and farmers to reduce the use of antimicrobials and vaccination, together with other measures, and this will help them to do this."
In the UK farmers will be able to carry out a DIY calculation of their return on investment online, using their smartphones or by visiting the Shiga toxin website www.shigatoxin.com
A Market Harborough-based practice - Town & Country Veterinary Centre - has announced that it is entering a team into a 10km obstacle course race so gruelling it is called 'The Suffering'.
The Suffering takes place in the grounds of Rockingham Castle, Leicestershire, on Saturday 12 March 2016. It includes more than 25 water, mud and rope-based obstacles.
The Town & Country team, which includes vets, nurses, students and receptionists, hopes to raise £1,000 for Vets for Change, which is fundraising to vaccinate dogs in Africa against rabies.
Michael Lander MRCVS said: "We are big supporters of the work of Vets for Change which is currently fundraising for its next mass vaccination programme in South Africa. The race does sound gruelling and I have done no training as yet although some of my colleagues have been hitting the gym for the past couple of months. We will all pull together on the big day and getting everyone round the course is our goal.
"We'd be very grateful for donations to help us reach our target for Vets for Change which does such fantastic work and have set up a just giving page at https://crowdfunding.justgiving.com/townandcountry-veterinarycentre."
The team members are: Sarah Kay Robinson (Receptionist), Chloe Brown (Receptionist), Zara Lander (VN), Katy Kirkham (VN), Kathleen Gamble (VN), Grace Costall (Student VN), Kate Bodley (Small Animal Vet), Michael Lander (Small Animal Vet), Lucinda Ticehurst (Equine Vet).
LacriProtect is designed to increase the depth of the tear film in the management of dry eye, during anaesthesia, or in case of irritation.
It contains a carbomer-based formula in individual, resealable single-use pipettes, so that each application is hygienic and free from cross-contamination.
This, says Samaxia, is particularly useful in clinical settings.
Lacri+ contains 0.4% cross-linked sodium hyaluronate and urea, and is designed to hydrate, lubricate and protect the ocular surface.
It comes in a multi-dispense bottle with a tip-seal mechanism and multilayer filtration to ensure sterility and give a shelf life of three months after opening.
https://www.samaxia.com
The dispensation was originally introduced during the spring 2020 lockdown to safeguard animal health and welfare, the health and safety of the veterinary team, and public health, by allowing prescriptions to be made by veterinary surgeons without their having first physically examined the animal, subject to conditions and safeguards.
The RCVS says the Committee considered the ongoing challenges posed by Covid-19 and recognised that staff absences due to isolation requirements were still causing issues.
However, given the relaxation of the requirement to work from home in England, Scotland and Northern Ireland and relaxation of restrictions generally across the UK, the Committee felt it was time to end the dispensation.
Chair of the Standards Committee, Dr Melissa Donald MRCVS, said: “The safety and wellbeing of veterinary professionals, as well as the health and welfare of the animals they care for, have remained uppermost in our minds when considering this temporary position on remote prescribing.
“We are pleased to have been able to support the professions through a very difficult time by introducing this dispensation, however, it was only ever a temporary measure and, given the relaxation of restrictions across the UK, we feel the time has come to revert to our usual guidance.
“We will continue to keep the position under review in light of any changes, including governments’ advice and regulations, as we have throughout the pandemic.”
There'll be tours of the hospital, including the new consulting suite, together with the opportunity to meet NWVS specialists, clinicians, nurses and client care personnel.
Food and refreshments will be served throughout the day, and the practice is also laying on some physiotherapy demonstrations.
Clinical director Prue Neath said: “Our open day for veterinary practice teams is a great opportunity to showcase to the veterinary profession the modern facilities and cutting-edge equipment we have on offer, further enhanced by our major expansion.
“The upgrades ensure we can continue to deliver the very best of care and treatments to our pet patients, while offering a first-class working environment for our valued colleagues.”
To book a place: www.nwspecialists.com/vet-professionals/open-day/registration
Fort Dodge, which supplies Bluetongue vaccine in continental Europe, has licensed its cattle vaccine in the UK and is now launching the product onto the UK market.
The company has already won and met tenders from several European governments, including France, Spain, Italy, Portugal Germany, Switzerland, Belgium and the Czech Republic for its Zulvac 8® Bovis vaccine and says it is the only international company to have produced vaccines for the most commonly occurring serotypes of the disease including 8, 4 and 1.
Approved by the VMD with a Provisional Marketing Authorisation, Zulvac 8 is available in 50 dose and 10 dose packs. The key claims are active immunisation against Bluetongue serotype 8 of cattle from 2.5 months old and a significant reduction of viraemia.
The vaccine is administered in 2 x 2 ml doses at three week intervals given by intra muscular injection and the product is supported by a fixed 2ml multidose applicator with Sterimatic needle protector and cleaning system to ensure accurate dosing and hygienic conditions.
John Hanley, Managing Director of Fort Dodge UK, said: "We were first to market with our Zulvac 8 product in three European countries and have received an Award for Agricultural Merit from the Spanish Government for our work in Bluetongue control. Following the licensing of Zulvac 8 Bovis in the UK we now have the opportunity to launch the product onto the UK market.
"In terms of pricing, Zulvac 8 is competitive per dose against other products in the market and it is supported by the experience gained in Europe with millions of animals already vaccinated. We're delighted that the VMD have authorised the vaccine and believe its availability can play a key role in protecting the UK's cattle from this dreadful disease."
The product is authorised for use by cattle farmers in the protection zone only, and will require veterinary prescription. Farmers can administer the vaccine to their cattle and the 2ml intra-muscular injection will be an advantage in aiding administration especially when used with Zulvac Bovis applicator with sterimatic needle protector and cleaning system.
The first batches will be available from veterinary wholesalers from week commencing 22nd September 2008.
Rimifin (carprofen), an NSAID marketed by Vetoquinol, has been given a new flavour to help increase compliance.
Robert Simpson, Product Manager for Rimifin said: "Pet owner compliance and involvement in chronic pain situations is critical to ensuring effective long term treatment. Ease of administration is also very important in this setting. The addition of this flavouring to this popular and cost effective NSAID will help to ensure that administration to the patient is as easy as possible for pet owners and vets."
To find out more about Rimifin please contact your Vetoquinol Territory Manager or call 01280 825424.
Topics covered will include practical applications of enrichment for zoo species, options for reproductive control in pet ferrets, challenges of exotics out-of-hours care, veterinary care of invertebrates and decision-making in wildlife cases.
The Association says that this year, there will be a greater focus on masterclasses, practical sessions and roundtable discussions, and that there will be plenty of new research, case reports, case series and the most recent advancements in the field of zoo, wildlife and exotic animal medicine.
There will be dedicated streams covering zoo health, nursing, exotic pets and wildlife health, together with a stream for students and new graduates.
The social programme includes the student-mentor mixer, a wine and canapés evening, a gala dinner and silent disco.
Registration fees have been held at the same level as 2019: tickets for non-members range from £410 for one day, to £760 for all three; members get a discount.
www.bvzs.co.uk
RCVS Council recommended the increase due to inflationary pressures and increased business costs.
Dr Tshidi Gardiner MRCVS, RCVS Treasurer, said: “We recognise that these are difficult economic times, so Council has endeavoured to limit the fee increase as far as possible; however, in proposing these new fees, Council has had to take account both of increased costs due to inflation, and of additional costs related to ensuring we are fulfilling our regulatory remit to the best of our abilities and meeting our strategic priorities.
“For example, increased costs related to the additional number of veterinary degrees coming on stream, modernising our membership database, our Charter Case Committee, the trial of our private prosecutions protocol against non-vets breaching the Veterinary Surgeons Act, and much more besides.”
Vets need to pay their annual renewal this year by 1st April.
Anyone who hasn't paid by 1st May will face a late payment charge of £35.
Anyone who hasn't paid by 1st June risks removal from the Register.
As part of the annual renewal process, vets also need to confirm their registration and contact details, declare any convictions and declare they are compliant with the College’s requirements for continuing professional development (CPD).
Anyone who expects to encounter any difficulties in paying their fees is asked to contact the RCVS Finance Team on finance@rcvs.org.uk or 020 7202 0722.
The Elekta Infinity linear accelerator is the only one of its kind for pets in England.
CVS says it allowing the centre to offer “cutting edge” image-guided radiation treatments for cancer in cats and dogs – meaning fewer, shorter sessions, fewer side effects and the best possible chance of improved outcomes for the animal.
Delphine Holopherne-Doran, Clinical Director at Bristol Vet Specialists, said: “Our new hospital is now at the forefront of cancer care in animals.
"We have invested in this state-of-the-art technology to bring cancer treatment in pets to the next level.
“Our unique linear accelerator allows us to offer advanced image-guided treatments - for example intensity-modulated or stereotactic radiation therapy.
"The advantage of these treatments is that high dose rates of focused beams are delivered with high precision over a shortened treatment course, with greater safety for the patient’s healthy tissue.
“It has now drawn many tumours into the realm of treatability, it is improving the quality of life for patients, and it is making it easier for owners to manage their pet’s treatment and aftercare.”
Still, the installation of the linear accelerator will probably have cost the same again, and then you've got the running costs.
That's not an inconsiderable cost per patient.
Intervet / Schering Plough Animal Health has launched Leventa, an easily administered once daily, liquid treatment for canine hypothyroidism.
Leventa is a low volume liquid formulation of levothyroxine sodium which provides the thyroxine needed by dogs with hypothyroidism. The company says it is readily accepted.
Until now, thyroxine has only been available in a tablet format. Leventa comes in a single presentation 30 ml bottle with a dosing syringe suitable for all weights of dogs, allowing straightforward storage and stock control.
Leventa enables accurate dosing and easy dose titration. The ready-to-dispense pack avoids time-consuming tablet dispensing and handling of medications.
In addition to the practical compliance benefits of the liquid format, Intervet / Schering Plough says Leventa also offers excellent bio-availability1. In trials, 79% of dogs stabilised on the once daily starting dose of 20g/kg avoiding lengthy stabilisation2.
Vicki Winslet, Veterinary Advisor at Intervet / Schering Plough said: "One of the greatest challenges faced by vets for effective treatment is owner compliance. Leventa overcomes this issue with a simple syringe dose replacing the need for tablets of varying sizes and quantities."
One of the most common endocrine disorders in dogs but difficult to diagnose, hypothyroidism can lead to a variety of issues including weight gain, lethargy and coat problems (including dullness, loss or thinning). It can also cause insulin resistance in diabetic dogs.
The launch of Leventa further extends Intervet / Schering Plough's endocrine portfolio which includes Caninsulin, developed for the treatment of diabetes in small animals and Vidalta, a once daily treatment for hyperthyroidism in cats which is already proving extremely popular with the profession.
For further information, please contact your Intervet/Schering-Plough account manager or telephone the company's Veterinary Support Group on 01908 685685.
1. Le Traon G, Burgaud S, Horspool LJ. (2008) Pharmacokinetics of total thyroxine in dogs after administration of an oral solution of levothyroxine sodium. J Vet Pharmacol Ther 31:95-101.2. Gommeren K, Benchekroun G, Brennan S.F, Burgaud S, Daminet S, Horspool L.J.I, Le Traon G, Rosenberg D, Mooney C.T (2008) A novel L-thyroxine solution is a safe and effective once daily treatment for canine hypothyroidism. In:Proceedings BSAVA congress 2008 , 3-6 April Birmingham, UK pp487-488
Genitrix has repackaged its palatable, fenbendazole-based treatment for internal parasites, with an easy dose syringe mechanism to allow its accurate administration to rabbits, ferrets, exotic birds and reptiles. To make life simpler for pet owners, it has also provided detailed dosing instructions for worming all the species for which it is indicated.
First launched in 2008, Lapizole is a broad spectrum oral-antiparasiticide for use in the prevention and treatment of infections caused by internal parasites of rabbits, birds, reptiles and ferrets, including Encephalitozoon cuniculi (E. cuniculi) in rabbits.
Genitrix' marketing director, Rob Watkins, said: "Lapizole proved itself as a highly effective treatment for E. cuniculi during its first year. Many of our customers have expressed the wish to use the treatment on a broader range of animals and in species groups for which highly accurate dosing and a syringe mechanism would be vital. We've taken their feedback on board and are delighted to be making Lapizole available to them with its new dispenser.
"The combination of efficacy, easy dosage and palatability make it an ideal product for the control of internal parasites in these species."
For more information, visit http://www.genitrix.co.uk/
The Royal Veterinary College has opened a new specialist ophthalmologist service at the Queen Mother Hospital for Animals (QMHA) in Hertfordshire.
According to the College, the service is equipped with the most up-to-date and state-of-the-art equipment available and will also benefit from the on-hand support of leading edge veterinary care at Europe's largest small animal hospital.
The RVC says all ophthalmology cases will be supported by dedicated anesthesiologists, whilst on an individual case basis the ophthalmologists will draw upon the expertise of specialists in imaging, oncology, neurology, emergency and critical care, internal medicine, dermatology, soft tissue and orthopedic surgery.
The following services will be available to all species on referral:
Rick F. Sanchez, who heads up the new service, holds a Diploma from the European College of Veterinary Ophthalmologists (DipECVO) and is currently the only Ophthalmology Diploma holder working in a UK university. In his new role Rick will be sharing his expertise gained from the 3 years intensive specialist training and 7 years in dedicated specialty practice with both undergraduate and postgraduate students at the college in a teaching role alongside his clinical and research responsibilities.
Rick said: "Returning to academia has been the realization of a long held professional dream and to do so by becoming part of the Royal Veterinary College has been a privilege and an honour. The superb team of specialists and dedicated nurses already established at the RVC creates a perfect environment to exercise clinical excellence and offer our animal patients the very best care we strive to provide as specialists.
"In addition, I see the creation of the new Ophthalmology Service as the final piece of the puzzle within the wide array of clinical expertise offered at QMHA. In my opinion it is this wide array of expertise that makes the QMHA at the RVC a leading centre for clinical, teaching and research excellence in veterinary medicine in the UK."
For more information please visit: http://www.rvc.ac.uk/QMH/Specialities/Ophthalmology.cfm